DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

222.16 -0.57 (-0.26%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IBB $222.16 -0.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $221.39
Previous Close $222.73
Daily Range $220.44 - $226.39
52-Week Range $163.41 - $275.40
Market Cap $4.5B
P/E Ratio -965.91
Dividend (Yield) $0.29 (0.0%)
Ex-Dividend Date
Dividend Pay Date
06/27/13
07/03/13
Volume 2,970,974
Average Daily Volume 3,481,820
Current FY EPS $0.00

Sector

Financials

Industry

Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website: http://www.ishares.com/

News & Commentary Rss Feed

Is This the Most Undervalued Biotech of 2013?

Biotechs roared in 2013. Questcor was no exception, but it still just might be the most undervalued biotech of the year.

Market Update: 5 Things We're Watching

Biotech, utilities, and other sectors are in play.

Expect Biotech Rally To Lead To Further Selling Of Research Stage Companies

Biotech: Where the Rubber Meets the Road

High-quality biotech stocks may be forming a durable bottom.

Google Earnings Are All About the Core

Traders should watch for volatility around Google's report.

Gilead: This Baby Has Been Thrown Away With The Bathwater

US Markets Take Another Wild Ride, With Utilities, Transports, and Financials on the Upswing

Today's financial recap and tomorrow's financial outlook.

The Correction As Seen In The ETP Landscape

Eight Serious Market Indicators to Watch During This Correction

Is Now The Time To Buy Ironwood Pharmaceuticals?

The Downside To Chasing Prior Winning Strategies

See More IBB News...

IBB's Top Competitors

IBB $222.16 (-0.26%)
Current stock: IBB
VTA $12.87 (0.31%)
Current stock: VTA
NCV $10.21 (0.79%)
Current stock: NCV
ZTR $14.04 (0.57%)
Current stock: ZTR